TUCSON, Ariz., Nov. 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the signing of a collaboration and ...
TUCSON, Ariz., March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its Accelerate ...
TUCSON, Ariz., March 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX) announced today that management will host a conference call on Thursday, March 28, 2024, at 4:30 p.m. Eastern Time to ...
Investors were encouraged by a recent award the company received in the effort to diagnose and treat sepsis more rapidly. Sepsis is a potentially fatal response from the body to an infection, and 1.7 ...
In response toreceivingFDA marketing authorization for two products, shares of Accelerate Diagnostics (NASDAQ: AXDX), a company focused onthe rapid diagnosis of infectious diseases, rose by 11% as of ...
BD (Becton, Dickinson and Co.) announced Aug. 15 a commercial collaboration under which the Franklin Lakes-based company will offer Accelerate Diagnostics Inc.’s rapid tests through its global sales ...
Accelerate Diagnostics (NASDAQ:AXDX) said Friday it priced an underwritten public offering of units and a concurrent private placement to raise up to $15 million. Shares -33.33% at $1.07 in early ...
Accelerate Diagnostics ( (AXDX)) has released its Q3 earnings. Here is a breakdown of the information Accelerate Diagnostics presented to its investors. Accelerate Diagnostics, Inc. is a company ...
TUCSON, Ariz., Aug. 17, 2022 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) ("Accelerate Diagnostics") today announced that it has commenced an underwritten public offering of shares of ...
The company's preliminary first quarter results saw gains, but executives are wary of what's next due to coronavirus uncertainty. Accelerate Diagnostics Inc. is teaming with BioCheck Inc. to fight the ...
This new testing platform will speed up health checks by determining whether asymptomatic people have COVID-19 antibodies in 30 minutes. On Tuesday, the two companies announced that the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results